Embrace Change Acquisition Corp - Rights에 대한 매도 수량은 투자자에게 Embrace Change Acquisition Corp - Rights의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Embrace Change Acquisition Corp - Rights (NASDAQ:EMCGR) 주식, 공매도 수량 보고

Embrace Change Acquisition Corp - Rights

<a href="https://www.benzinga.com/startups/24/11/42038731/jamie-dimon-warns-of-stagflation-looming-on-the-horizon-heres-the-financial-plan-experts-say-you-should-put-into-action-now">Jamie Dimon</a>, CEO of JPMorgan Chase, and Elon Musk, CEO of Tesla and SpaceX, have reportedly reconciled after years of public feuds and legal disputes. <a href="https://youtu.be/ii08sxvgo-g">In an interview</a> with CNBC's Squawk Box aired Wednesday, Dimon said the two had "hugged it out" following a long discussion earlier this year.
"He came to one of our conferences, he and I had a nice long chat and we've settled some of our differences," Dimon said.&nbsp;
Musk attended JPMorgan's tech summit in March, where the two reportedly spoke for an hour onstage and later privately in Dimon's suite, Business Insider reported, citing sources familiar with the matter.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
</ul>
Dimon went on to express support for Musk's leadership of the <a href="https://www.benzinga.com/startups/24/12/42508653/bernie-sanders-supports-elon-musks-doge-stating-that-it-must-target-the-pentagons-886-billion-budget">Department of Government Efficiency (DOGE)</a>, a federal initiative created by an executive order signed Monday by President Donald Trump.&nbsp;
Musk initially pitched DOGE in August as a tool to cut federal spending and reduce regulations. However, DOGE's current focus is on modernizing the government's aging IT systems and software infrastructure.
"We deserve good government," Dimon told CNBC. "I don't think anyone believes sending another trillion dollars to Washington guarantees good governance. Government needs to be more accountable, more efficient and outcomes-based."
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a>
DOGE's creation follows a live-streamed conversation between Musk and Trump on X, formerly Twitter, where Musk offered to help lead a government efficiency commission. Trump, who has long criticized government spending, reportedly welcomed Musk's involvement.&nbsp;
Musk backed his words with <a href="https://www.benzinga.com/personal-finance/24/09/41082731/new-survey-finds-75-of-americans-support-cuts-for-higher-income-retirees-to-cover-social-security-shortfall">financial support</a>, spending over $200 million during the 2024 election cycle to support Trump's reelection and other Republican candidates, The New York Times reported.
Musk's commitment to DOGE comes as U.S. government spending hit $7 trillion in 2024, with over $90 billion allocated annually to federal IT budgets, according to the Government Accountability Office.&nbsp;
Much of that spending goes toward maintaining outdated systems, which experts say are costly and inefficient. Modernizing these systems could save billions, but the challenge of overhauling government technology is enormous.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Dimon acknowledged the scale of the task ahead, saying, "It's going to be complicated. The federal government is a massive operation. If we can help in any way, I'd love to be helpful."
Dimon has long favored government efficiency. In a <a href="https://youtu.be/ii08sxvgo-g">September 2024 interview</a> with CNBC-TV18, he stated, "I think governments have to become more efficient, more competent and look at, when they take money, what they get for it.&#8221; He further remarked, &#8220;We really need to do it.&#8221;&nbsp;
The reconciliation between Dimon and Musk follows years of disputes, including a 2021 lawsuit where JPMorgan sued Tesla for $162 million over alleged breaches of a stock warrants contract.&nbsp;
The disagreement stemmed from Musk's infamous 2018 tweet about taking Tesla private, which he later retracted. Tesla countersued, accusing JPMorgan of bad faith. Both lawsuits were dropped in November 2024, with the case dismissed with prejudice.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

Jamie Dimon Calls Elon Musk 'Our Einstein' After Years Of Feuds: 'We've Hugged It Out' And Settled Differences At Tech Summit

In the current session, the stock is trading at $21.52, after a 0.99% increase. Over the past month, Kenvue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) stock increased by 0.89%, and in the past year, by 3.07%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1738248311_0.png" alt="Past Year Chart" />

<h3>Kenvue P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Kenvue has a lower P/E than the aggregate P/E of 42.64 of the Personal Products industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1738248311_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

KVUE

A Look Into Kenvue Inc's Price Over Earnings

Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) has outperformed the market over the past 10 years by 4.84% on an annualized basis producing an average annual return of 16.3%. Currently, Ciena has a market capitalization of $11.94 billion. 
Buying $100 In CIEN: If an investor had bought $100 of CIEN stock 10 years ago, it would be worth $446.54 today based on a price of $84.00 for CIEN at the time of writing.
<h3>Ciena's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738248309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CIEN

Here's How Much You Would Have Made Owning Ciena Stock In The Last 10 Years

JP Morgan analyst John Ivankoe maintains Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) with a Neutral and raises the price target from $140 to $160.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Brinker International, Raises Price Target to $160

Dover Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) shares are trading higher on Thursday after the&nbsp;company<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43330990/dover-reports-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener"> reported&nbsp;fourth-quarter&nbsp;results</a>.
Revenue stood at $1.93 billion, an increase of 1% year-over-year, missing the consensus of $1.95 billion. 
Segment earnings margin expanded 50 bps Y/Y to 22.2%. Total adjusted segment EBITDA margin expanded to 24.2% from 23.5% a year ago.
Margin improved aided by favourable mix from the high margin, high growth platforms, and strict cost containment and productivity actions.
The company expects ongoing productivity and cost containment actions to benefit consolidated margins in 2025.
Booking increased&nbsp;8% Y/Y to&nbsp;$1.939 billion&nbsp;in the quarter. Adjusted EPS was&nbsp;$2.20, up&nbsp;1%&nbsp;Y/Y, beating <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of&nbsp;$2.08</a>.
Operating cash flow for the year totaled&nbsp;$1.09 billion, and free cash flow was&nbsp;$920.3 million.
2025 Outlook:&nbsp;Dover expects adjusted EPS of&nbsp;$9.30–$9.50&nbsp;(consensus of&nbsp;$9.31)&nbsp;and&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">organic revenue growth&nbsp;of 3%–5%</a>.
Dover's President and Chief Executive Officer, Richard J. Tobin, said, &#8221;Order trends continued their positive trajectory in the quarter with book-to-bill above one, driven by robust bookings in our secular-growth-exposed markets in single-use biopharma components, thermal connectors, and CO2 systems.&#8221;
&#8220;We are optimistic about 2025. Underlying demand trends remain solid across the portfolio, as evidenced by our order momentum, and we have significant runway for continued margin improvement through positive mix benefits and numerous cost and performance levers.&#8221;&nbsp;&nbsp;
&#8221;With this backdrop, we are poised to deliver double-digit EPS growth in 2025 through a combination of accretive top line growth, margin improvement, and value-creating capital allocation.&#8221;
Investors can gain exposure to the stock via Siren DIVCON Dividend Defender ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/DFND#BATS">DFND</a>).
Price Action: DOV shares are up 4.75% at $206.73 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43335926" target="_blank" rel="noreferrer noopener">Comcast&nbsp;Q4&nbsp;Earnings Beat Estimates: Peacock Subscribers Surge&nbsp;29%, Dividend Raised,&nbsp;$15 Billion&nbsp;Buyback Approved</a></li>
</ul>

Earnings

Equities

Large Cap

Guidance

Movers

DFND

Dover Delivers Strong Q4 Margins & EPS Beat, Stock Climbs On 2025 Optimism

WIIM

Altria Group shares are trading lower. The company reported Q4 financial results.

Stephens &amp; Co. analyst Mason Carrico downgrades Paragon 28 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNA#NYSE">FNA</a>) from Overweight to Equal-Weight and lowers the price target from $14 to $13.

Downgrades

Stephens & Co. Downgrades Paragon 28 to Equal-Weight, Lowers Price Target to $13

AMOD

Alpha Modus Shares Resume Trade

https://clinicaltrials.gov/study/NCT06780449?spons=Novo%20Nordisk%20A%2FS&amp;titles=cagrisema&amp;rank=6`

Biotech

General

Novo Nordisk To Begin New Phase III Trial Of Obesity Drug Candidate Cagrisema

JMP Securities analyst Nicholas Jones reiterates Upwork (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) with a Market Outperform and maintains $18 price target.

Reiteration

UPWK

JMP Securities Reiterates Market Outperform on Upwork, Maintains $18 Price Target

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Southern Missouri Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMBC#NASDAQ">SMBC</a>) with a Market Perform and lowers the price target from $70 to $68.

SMBC

Keefe, Bruyette & Woods Maintains Market Perform on Southern Missouri Bancorp, Lowers Price Target to $68

Scotiabank analyst Maher Yaghi maintains T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) with a Sector Perform and raises the price target from $234 to $247.

TMUS

Scotiabank Maintains Sector Perform on T-Mobile US, Raises Price Target to $247

JMP Securities analyst Karol Chmiel reiterates Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) from Market Perform to Market Perform.

SIGI

JMP Securities Reiterates Market Perform on Selective Insurance Grto Market Perform

ONEW

OneWater Marine Shares Halted On Circuit Breaker To The Downside, Stock Now Up 10.8%

Keefe, Bruyette &amp; Woods analyst Aidan Hall reiterates SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) with a Market Perform and raises the price target from $86 to $90.

SEIC

Keefe, Bruyette & Woods Reiterates Market Perform on SEI Inv, Raises Price Target to $90

JMP Securities analyst Devin Ryan maintains Stifel Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SF#NYSE">SF</a>) with a Market Outperform and raises the price target from $125 to $135.

JMP Securities Maintains Market Outperform on Stifel Financial, Raises Price Target to $135

Keefe, Bruyette &amp; Woods analyst Catherine Mealor reiterates Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) with a Outperform and raises the price target from $45 to $46.

RNST

Keefe, Bruyette & Woods Reiterates Outperform on Renasant, Raises Price Target to $46

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Market Perform and raises the price target from $170 to $177.

Keefe, Bruyette & Woods Maintains Market Perform on Raymond James Finl, Raises Price Target to $177

Alpha Modus Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 140.3%

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) with a Market Perform and lowers the price target from $37 to $35.

Comments

Embrace Change Acquisition Corp - Rights

매도 수량

Embrace Change Acquisition Corp - Rights (NASDAQ:EMCGR) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌